Table 1.

Main Indication groups for MARS^® therapy

1	Acute liver failure
2	Acute decompensation on chronic liver disease
	Complicated by progressive jaundice
	Complicated by hepatic encephalopathy
	Complicated by renal dysfunction
3	Intractable pruritus in cholestasis
4	Acute intoxication or overdose with substances potentially bound to albumin
5	Other indications
	Acute hepatic failure after major hepatectomy
	After liver transplantation
	Primary non-function or primary dysfunction of the graft
	Acute decompensation of the graft (disease recurrence...)
	Secondary liver failure or multi-organ failure